We’re excited to announce our March new hires: Alexandre Ruinet, Michael Arredondo, David Mackey, Timothy J. Lee, and George Martinez.? We are thrilled to have you on board and excited for the contributions you’ll bring. At Cerus, we believe in collaboration and fostering a supportive environment where everyone can thrive. We look forward to seeing your talents in action and growing together. Welcome aboard!?
Cerus
生物技术研究
Concord,California 9,986 位关注者
At Cerus, we are proud of our consistent and unwavering focus to secure blood safety around the globe.
关于我们
Cerus Corporation is dedicated solely to safeguarding the world’s blood supply and aims to become the preeminent global blood products company. Headquartered in Concord, California, the company develops and supplies vital technologies and pathogen-protected blood components to blood centers, hospitals, and ultimately patients who rely on safe blood. The INTERCEPT Blood System for platelets and plasma is available globally and remains the only pathogen reduction system with both CE mark and FDA approval for these two blood components. In the US, the INTERCEPT Blood System for Cryoprecipitation is approved for the production of Pathogen Reduced Cryoprecipitated Fibrinogen Complex (commonly referred to as INTERCEPT Fibrinogen Complex), a therapeutic product for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. The INTERCEPT red blood cell system is in late-stage clinical development. For more information about Cerus, visit www.cerus.com and follow us on LinkedIn.
- 网站
-
https://www.cerus.com
Cerus的外部链接
- 所属行业
- 生物技术研究
- 规模
- 201-500 人
- 总部
- Concord,California
- 类型
- 上市公司
- 创立
- 1992
- 领域
- blood safety、pathogen inactivation、hospital safety、patient safety、pandemic preparedness、plasma、pathogen reduction、blood supply、healthcare、public health、transfusion medicine、platelets和bleeding
地点
Cerus员工
动态
-
?? National Physicians Week | March 25–31, 2025 ??? This week, we celebrate the dedication and resilience of physicians who work tirelessly to protect and improve patient health. The theme promoted by Physicians Working Together, “Together We Thrive”, reminds us that collaboration and innovation are essential to advancing medical care. At Cerus, we recognize the vital role physicians play in ensuring safe and effective blood transfusions for patients worldwide. Through pathogen inactivation, we remain committed to supporting physicians with technologies designed to help reduce transfusion risks and to help maintain the integrity of the blood supply. Join us in celebrating physicians this week!? Tag a doctor who has made a difference in your life. ???? #NationalPhysiciansWeek #PhysiciansWorkingTogether #TogetherWeThrive #BloodSafety?#cerus
-
-
In our latest webinar, Dr. Allison P Wheeler from WACBD - Washington Center for Bleeding Disorders presents key findings from the PIPER Study, the largest Phase IV prospective study of platelet transfusion-associated pulmonary injury to-date.? ?? View the full webinar here: https://lnkd.in/gMmVPyhy? ?? #platelets #pathogeninactivation #bloodsafety #transfusionmedicine?#cerus ?
-
-
Centers for Disease Control and Prevention just published the latest results of the 2023 National Blood Collection and Utilization Survey (NBCUS) in which national trends in US blood availability are described (1). Findings include:? ? Responses from 96% of community-based blood centers and 85.7% of transfusing hospitals, the highest to date?? ? Stabilization in the blood supply with a return to pre-COVID-19 pandemic levels? ? Shift from whole-blood derived platelets in favor of apheresis platelets, the former of which have been associated with a higher risk of viral transfusion transmission?due to multiple donor exposure? ? More than half of the nation’s supply of apheresis platelets are pathogen reduced?? ?? Read more about the NBCUS (https://lnkd.in/gF_bycEc)? ?? #bloodavailability #patientsafety #transfusionmedicine #pathogenreduction??#cerus (1) McDavid K, et al. Transfusion. 2025 Mar 11. Epub ahead of print.?
-
?? Patient Safety Awareness Week | March 9–15, 2025 ?? Patient safety is at the heart of everything we do. During Patient Safety Awareness Week, we recognize the progress made in healthcare safety, and all the dedicated individuals behind that progress, including @ptsafetyexpert. We also acknowledge the urgent need to do more to ‘move the needle’ -- preventable harm remains a global public health challenge, impacting millions of lives each year. At Cerus, we are committed to advancing the blood transfusion safety by reducing the risk of transfusion-transmitted infections. A safer blood supply requires innovation, collaboration, and continued investment in technologies like pathogen reduction.? We all have a role to play in making healthcare safer. Join us in recognizing this week and advocating for solutions that put patient safety first.?? #PSAW25 #PatientSafety #BloodSafety #PathogenReduction #PathogenInactivation ?
-
-
Reflecting on 5 Years Since the COVID-19 Pandemic Declaration ? Five years ago today, the World Health Organization declared COVID-19 a global pandemic. This milestone marked the beginning of a profoundly challenging time that reshaped healthcare systems, economies, and our daily lives across the globe. As we reflect on the lessons learned and the resilience shown by communities everywhere, we also honor the healthcare workers, blood donors, researchers, and countless others who stepped up in extraordinary ways to protect lives and strengthen public health systems. The pandemic underscored the critical importance of safe and reliable blood supplies and highlighted the need for innovation in transfusion medicine. At Cerus, we remain committed to advancing technologies that support blood safety and pandemic preparedness. Learn more about our work here: https://www.cerus.com/? #COVID19Anniversary #PandemicPreparedness #BloodSafety #GlobalHealth?
-
Cerus is proud to be a sponsor for America’s Blood Centers’ (ABC) Annual Meeting to be held in Arlington, VA from March 10-12th. Dr. Nina Mufti, Sr. VP of Research and Development at Cerus, has been invited to present as part of ABC’s “New Products and Technology Showcase” session on March 11th, where she’ll discuss perspectives on protecting the blood supply with pathogen reduction. We look forward to seeing you there!? ? #ABC2025 #patientsafety #transfusionmedicine #pathogenreduction???
-
Today, Cerus announced receipt of CE mark for next-generation INTERCEPT Illumination Device (INT200). You can read the full press release here: https://ow.ly/wMNc50Vbfrj
-
-
March is American Red Cross Month ? This month, we honor the incredible volunteers and humanitarian work of the American Red Cross, who provide critical services across the globe—from disaster relief to emergency assistance, and so much more. Their efforts save lives, rebuild communities, and bring hope to those in need. At Cerus, we deeply respect the mission of the Red Cross and are proud to support their efforts, especially in the areas of blood donation and emergency care. Volunteers are the backbone of their work, and this month, we celebrate all the individuals who give their time, energy, and compassion to help others in times of crisis. Let’s take a moment to acknowledge the selflessness of Red Cross volunteers and find ways we can all contribute to making the world a better place. ?? Learn how you can volunteer or support the American Red Cross: redcross.org #RedCrossMonth #HelpCantWait #Volunteer #HumanitarianWork #RedCross #CommunitySupport?
-
The Cerus story is a unique one, addressing the need for blood safety and availability over 30+ years. With this history comes the need to communicate our mission to many different audiences. Learn more about how we’ve done this in Jessica Hanover's conversation with Kimberly Kraemer of life sciences agency Waterhouse Brands. https://lnkd.in/g2kPdHf4?
There's a lot to be said for taking a "career portfolio" approach when it comes to leading the Corporate Affairs function at life sciences companies. That's because navigating complex competitive dynamics and representing diverse audience needs is THE JOB. So what skills and experiences position someone for success in this mission-critical C-suite role? To explore this question, I sat down with Jessica Hanover, Ph.D., whose career trajectory to the C-Suite of Cerus working with CEO William "Obi" Greenman paints a picture of how in-the-trenches scientific and technical experiences become a force multiplier for strong communications skills in leading the Corporate Affairs function. My take: there's no one-size-fits-all approach to doing the job, but doing it well requires diversity of perspective. Read on…